Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings

Journal of Infectious Diseases

Volumn 210, Issue 3, 2014, Pages 424-434

  Zhang, Xiaoming ^a,c,h   Casartelli, Nicoletta ^b,d   Lemoine, Sebastien ^a,c   Mozeleski, Brian ^a,c   Azria, Elie ^e,f   Le Ray, Camille ^f,g   Schwartz, Olivier ^b,d   Launay, Odile ^c,f,g   Leclerc, Claude ^a,c   Lo Man, Richard ^a,c  

^a INSTITUT PASTEUR   (France)

^b Institute Pasteur Korea   (South Korea)

^c INSERM   (France)

^d URA CNRS 3015   (South Korea)

^e BICHAT HOSPITAL   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^h INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

Influenza Vaccine; Newborn; Plasmacytoid dendritic cells; Th1

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 12; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INTERLEUKIN 22; MEASLES VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; TOLL LIKE RECEPTOR;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MOTILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LYMPHOCYTE DIFFERENTIATION; NEWBORN; PLASMACYTOID DENDRITIC CELL; POLARIZATION; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; ADULT; ANTIGEN PRESENTING CELL; IMMUNOSTIMULATION; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; UMBILICAL CORD BLOOD;

INFLUENZA VACCINE; NEWBORN; PLASMACYTOID DENDRITIC CELLS; TH1;

AGING; DENDRITIC CELLS; FETAL BLOOD; HUMANS; IMMUNIZATION SCHEDULE; INFANT, NEWBORN; INFLUENZA VACCINES; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-12; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; VACCINATION;

EID: 84902791418     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu103     Document Type: Article

References (34)

1. Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011; 12:786-95.
2. Prabhudas M, Adkins B, Gans H, et al. Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 2011; 12:189-94.
3. Marchant A, Goetghebuer T, Ota MO, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999; 163:2249-55.
4. Burl S, Townend J, Njie-Jobe J, et al. Age-dependent maturation of Tolllike receptor-mediated cytokine responses in Gambian infants. PLoS One 2011; 6:e18185.
5. Kollmann TR, Crabtree J, Rein-Weston A, et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009; 183:7150-60.
6. Lisciandro JG, Prescott SL, Nadal-Sims MG, et al. Ontogeny of Toll-like and NOD-like receptor-mediated innate immune responses in Papua New Guinean infants. PLoS One 2012; 7:e36793.
7. Nguyen M, Leuridan E, Zhang T, et al. Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS One 2010; 5: e10407.
8. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4:553-64.
9. Levy O, Coughlin M, Cronstein BN, Roy RM, Desai A,Wessels MR. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J Immunol 2006; 177:1956-66.
10. Upham JW, Lee PT, Holt BJ, et al. Development of interleukin-12-producing capacity throughout childhood. Infect Immun 2002; 70: 6583-8.
11. Sun C, Deriaud E, Leclerc C, Lo-Man R. Upon TLR9 signaling, CD5(+) B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 2005; 22:467-77.
12. Zhang X, Deriaud E, Jiao X, Braun D, Leclerc C, Lo-Man R. Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med 2007; 204:1107-18.
13. Goriely S, Van Lint C, Dadkhah R, et al. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J Exp Med 2004; 199:1011-6.
14. De Wit D, Olislagers V, Goriely S, et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004; 103:1030-2.
15. Zhang S, Lepelley A, Azria E, et al. Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses. PLoS One 2013; 8:e52003.
16. Ota MO, Vekemans J, Schlegel-Haueter SE, et al. Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002; 168:919-25.
17. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of singlestranded RNA. Science 2004; 303:1529-31.
18. Koyama S, Aoshi T, Tanimoto T, et al. Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci Transl Med 2010; 2:25ra4.
19. Jurk M, Heil F, Vollmer J, et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002; 3:499.
20. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skinhoming memory T cells. Nat Immunol 2009; 10:857-63.
21. Hoeffel G, Ripoche A-C, Matheoud D, et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 2007; 27:481-92.
22. Fonteneau JF, Guillerme JB, Tangy F, Gregoire M. Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells. Oncoimmunology 2013; 2:e24212.
23. Takaki H, Takeda M, Tahara M, et al. The MyD88 pathway in plasmacytoid and CD4+ dendritic cells primarily triggers type I IFN production against measles virus in a mouse infection model. J Immunol 2013; 191:4740-7.
24. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283:1183-6.
25. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 2000; 1:305-10.
26. Hanabuchi S, Ito T, Park WR, et al. Thymic stromal lymphopoietinactivated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J Immunol 2010; 184: 2999-3007.
27. Yu C-F, Peng W-M, Oldenburg J, et al. Human plasmacytoid dendritic cells support Th17 cell effector function in response to TLR7 ligation. J Immunol 2010; 184:1159.
28. Villadangos JA, Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008; 29:352-61.
29. Gold MC, Robinson TL, Cook MS, et al. Human neonatal dendritic cells are competent in MHC class I antigen processing and presentation. PLoS One 2007; 2:e957.
30. Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V. Plasmacytoid Dendritic Cells: Recent Progress and Open Questions. Annu Rev Immunol 2011; 29:163-83.
31. He XS, Holmes TH, Zhang C, et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 2006; 80:11756-66.
32. Vekemans J, Ota MO, Wang EC, et al. T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol 2002; 127:495-8.
33. Hoft DF, Babusis E, Worku S, et al. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 2011; 204:845-53.
34. Walter EB, Englund JA, Blatter M, et al. Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study. Pediatr Infect Dis J 2009; 28:1099-104.